CI
CRYOPORT, INC.
StreetZero Signal 56
About CRYOPORT, INC.
Cryoport, Inc. provides cryogenic logistics and supply chain solutions for the life sciences industry, focusing on the transportation and storage of temperature-sensitive biological materials including cell and gene therapies. The company is headquartered in Brentwood, TN and was founded in 1999 as a public company listed on NASDAQ under ticker CYRX. It operates in the transportation, logistics, supply chain and storage sector with approximately 688 employees.
LATEST FUNDINGRule 144
$199K
Announced 2026-11-10
TOTAL RAISED$1.11B
IN THE NEWS
- π CRYOPORT, INC.
- π Cryoport Announces Pricing of Public Offering of Common Stock :: Cryoport, Inc. (CYRX)
- π Cryoport Announces Pricing of Public Offering of Common Stock
- π Cryoport proxy: director votes, equity plan, 2026 outlook
- π Cryoport Inc μ€λμ μ£Όκ° | CYRX μ€μκ° ν°μ»€ - Investing.com
EMPLOYEES688
FOUNDED1999
HQBrentwood, TN, United States
Industry
Public Equity (NASDAQ)
Tags
LogisticsCold ChainLife SciencesPublic
Investors
Key highlights
- Completed $350M Post-IPO Debt round in 2021
- Total funding across 12 rounds reached 1.11B USD
- Focuses on cell and gene therapy supply chain logistics
- Public company on NASDAQ: CYRX with 688 employees
Ask StreetZero about CRYOPORT, INC.
Put our AI to work on this deal.
Similar companies
Other Public Equity (NASDAQ) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account